NARCOLEPSY
Clinical trials for NARCOLEPSY explained in plain language.
Never miss a new study
Get alerted when new NARCOLEPSY trials appear
Sign up with your email to follow new studies for NARCOLEPSY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New narcolepsy drug shows promise in early trial
Symptom relief TerminatedThis early-stage study tested an experimental drug called MK-6552 in 9 people with narcolepsy type 1, a condition that causes sudden sleep attacks. The goal was to see if the drug is safe and can help people stay awake during the day. Participants took the drug for a week, and re…
Matched conditions: NARCOLEPSY
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Symptom relief
Last updated May 26, 2026 06:56 UTC
-
Narcolepsy drug trial halted early: did it work?
Symptom relief TerminatedThis early-stage study tested an experimental drug called JZP441 in 6 adults with narcolepsy type 1, a condition that causes sudden sleep attacks. The goal was to see if the drug helps people stay awake during the day and to check for side effects. The trial was terminated early,…
Matched conditions: NARCOLEPSY
Phase: PHASE1 • Sponsor: Jazz Pharmaceuticals • Aim: Symptom relief
Last updated May 22, 2026 14:02 UTC